The mission of The Alpha-1 Project describes the collaborative nature of the pursuit of our vision and how the initiative will build upon the current knowledge base that has been established through projects funded by the Alpha-1 Foundation and/or other organizations.
The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures and therapies for COPD and liver diseases caused by Alpha-1 Antitrypsin Deficiency.